| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |